Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts

Young Woo Eom, Jong Eun Lee, Mal Sook Yang, In Keun Jang, Hyo Eun Kim, Doo Hoon Lee, Young Jin Kim, Won Jin Park, Jee Hyun Kong, Kwang Yong Shim, Jong In Lee, Hyunsoo Kim

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Stem cell therapy for muscular dystrophies requires stem cells that are able to participate in the formation of new muscle fibers. However, the differentiation steps that are the most critical for this process are not clear. We investigated the myogenic phases of human adipose tissue-derived stem cells (hASCs) step by step and the capability of myotube formation according to the differentiation phase by cellular fusion with mouse myoblast C2C12 cells. In hASCs treated with 5-azacytidine and fibroblast growth factor-2 (FGF-2) for 1. day, the early differentiation step to express MyoD and myogenin was induced by FGF-2 treatment for 6. days. Dystrophin and myosin heavy chain (MyHC) expression was induced by hASC conditioned medium in the late differentiation step. Myotubes were observed only in hASCs undergoing the late differentiation step by cellular fusion with C2C12 cells. In contrast, hASCs that were normal or in the early stage were not involved in myotube formation. Our results indicate that stem cells expressing dystrophin and MyHC are more suitable for myotube formation by co-culture with myoblasts than normal or early differentiated stem cells expressing MyoD and myogenin.

Original languageEnglish
Pages (from-to)167-173
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume408
Issue number1
DOIs
Publication statusPublished - 2011 Apr 29

Fingerprint

Dystrophin
Myosin Heavy Chains
Myoblasts
Skeletal Muscle Fibers
Stem cells
Adipose Tissue
Fusion reactions
Stem Cells
Tissue
Myogenin
Fibroblast Growth Factor 2
Azacitidine
Fibroblast Growth Factor 1
Muscular Dystrophies
Conditioned Culture Medium
Cell- and Tissue-Based Therapy
Coculture Techniques
Cell culture
Muscle
Muscles

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Eom, Young Woo ; Lee, Jong Eun ; Yang, Mal Sook ; Jang, In Keun ; Kim, Hyo Eun ; Lee, Doo Hoon ; Kim, Young Jin ; Park, Won Jin ; Kong, Jee Hyun ; Shim, Kwang Yong ; Lee, Jong In ; Kim, Hyunsoo. / Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts. In: Biochemical and Biophysical Research Communications. 2011 ; Vol. 408, No. 1. pp. 167-173.
@article{13fd19c70f5847cd9e5808d6c7732683,
title = "Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts",
abstract = "Stem cell therapy for muscular dystrophies requires stem cells that are able to participate in the formation of new muscle fibers. However, the differentiation steps that are the most critical for this process are not clear. We investigated the myogenic phases of human adipose tissue-derived stem cells (hASCs) step by step and the capability of myotube formation according to the differentiation phase by cellular fusion with mouse myoblast C2C12 cells. In hASCs treated with 5-azacytidine and fibroblast growth factor-2 (FGF-2) for 1. day, the early differentiation step to express MyoD and myogenin was induced by FGF-2 treatment for 6. days. Dystrophin and myosin heavy chain (MyHC) expression was induced by hASC conditioned medium in the late differentiation step. Myotubes were observed only in hASCs undergoing the late differentiation step by cellular fusion with C2C12 cells. In contrast, hASCs that were normal or in the early stage were not involved in myotube formation. Our results indicate that stem cells expressing dystrophin and MyHC are more suitable for myotube formation by co-culture with myoblasts than normal or early differentiated stem cells expressing MyoD and myogenin.",
author = "Eom, {Young Woo} and Lee, {Jong Eun} and Yang, {Mal Sook} and Jang, {In Keun} and Kim, {Hyo Eun} and Lee, {Doo Hoon} and Kim, {Young Jin} and Park, {Won Jin} and Kong, {Jee Hyun} and Shim, {Kwang Yong} and Lee, {Jong In} and Hyunsoo Kim",
year = "2011",
month = "4",
day = "29",
doi = "10.1016/j.bbrc.2011.04.002",
language = "English",
volume = "408",
pages = "167--173",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts. / Eom, Young Woo; Lee, Jong Eun; Yang, Mal Sook; Jang, In Keun; Kim, Hyo Eun; Lee, Doo Hoon; Kim, Young Jin; Park, Won Jin; Kong, Jee Hyun; Shim, Kwang Yong; Lee, Jong In; Kim, Hyunsoo.

In: Biochemical and Biophysical Research Communications, Vol. 408, No. 1, 29.04.2011, p. 167-173.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts

AU - Eom, Young Woo

AU - Lee, Jong Eun

AU - Yang, Mal Sook

AU - Jang, In Keun

AU - Kim, Hyo Eun

AU - Lee, Doo Hoon

AU - Kim, Young Jin

AU - Park, Won Jin

AU - Kong, Jee Hyun

AU - Shim, Kwang Yong

AU - Lee, Jong In

AU - Kim, Hyunsoo

PY - 2011/4/29

Y1 - 2011/4/29

N2 - Stem cell therapy for muscular dystrophies requires stem cells that are able to participate in the formation of new muscle fibers. However, the differentiation steps that are the most critical for this process are not clear. We investigated the myogenic phases of human adipose tissue-derived stem cells (hASCs) step by step and the capability of myotube formation according to the differentiation phase by cellular fusion with mouse myoblast C2C12 cells. In hASCs treated with 5-azacytidine and fibroblast growth factor-2 (FGF-2) for 1. day, the early differentiation step to express MyoD and myogenin was induced by FGF-2 treatment for 6. days. Dystrophin and myosin heavy chain (MyHC) expression was induced by hASC conditioned medium in the late differentiation step. Myotubes were observed only in hASCs undergoing the late differentiation step by cellular fusion with C2C12 cells. In contrast, hASCs that were normal or in the early stage were not involved in myotube formation. Our results indicate that stem cells expressing dystrophin and MyHC are more suitable for myotube formation by co-culture with myoblasts than normal or early differentiated stem cells expressing MyoD and myogenin.

AB - Stem cell therapy for muscular dystrophies requires stem cells that are able to participate in the formation of new muscle fibers. However, the differentiation steps that are the most critical for this process are not clear. We investigated the myogenic phases of human adipose tissue-derived stem cells (hASCs) step by step and the capability of myotube formation according to the differentiation phase by cellular fusion with mouse myoblast C2C12 cells. In hASCs treated with 5-azacytidine and fibroblast growth factor-2 (FGF-2) for 1. day, the early differentiation step to express MyoD and myogenin was induced by FGF-2 treatment for 6. days. Dystrophin and myosin heavy chain (MyHC) expression was induced by hASC conditioned medium in the late differentiation step. Myotubes were observed only in hASCs undergoing the late differentiation step by cellular fusion with C2C12 cells. In contrast, hASCs that were normal or in the early stage were not involved in myotube formation. Our results indicate that stem cells expressing dystrophin and MyHC are more suitable for myotube formation by co-culture with myoblasts than normal or early differentiated stem cells expressing MyoD and myogenin.

UR - http://www.scopus.com/inward/record.url?scp=79955366016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955366016&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.04.002

DO - 10.1016/j.bbrc.2011.04.002

M3 - Article

C2 - 21473854

AN - SCOPUS:79955366016

VL - 408

SP - 167

EP - 173

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -